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In this issue of Annals of Intensive Care, Van Regenmor-
tel et  al. report a significant association between hyper-
chloremia present on the first day of intensive care unit 
(ICU) admission and ICU and hospital mortality in a 
large cohort of ICU patients. However, chloride levels 
were significantly higher and mortality was lower in car-
diac surgery patients than in the entire cohort [1].
Hyperchloremia is increasingly stigmatized to nega-
tively influence kidney function and mortality in ICU 
patients. Paradoxically, normal saline (NaCl 0.9%; NS)—
the worldwide number one solution for patient resuscita-
tion purposes—contains supraphysiologic concentrations 
of chloride and, when amply infused, inevitably causes 
hyperchloremic metabolic acidosis (HMA) [2]. Animal 
models typically highlight the adverse and unwarranted 
effects of NS-induced HMA such as greater hemody-
namic instability, altered microcirculation, and enhanced 
or persistent inflammation [3, 4]. Growing aversion for 
NS produced a surge of studies comparing NS with dif-
ferent “balanced” crystalloid solutions. The latter (i.e., 
Ringer’s solution, Hartmann’s solution, and Plasma-
Lyte®) more closely resemble the electrolyte component 
of plasma but, most importantly, contain much less chlo-
ride than NS (109, 111, and 98 mmol/L, respectively).
Basically, the case against NS is entirely built on its 
disruptive effect on acid–base homeostasis. Among 
the different viewpoints on acid–base equilibrium, the 
Stewart–Figge approach explains NS-induced acidosis 
by an increase in chloride anion concentration. Accord-
ing to this method, the apparent strong ion difference 
(SIDa) is an independent variable that is unaltered by 
unidirectional sodium and chloride changes and thus a 
more appropriate detector of fluid-related HMA [5]. As 
the SIDa of NS equals zero, infusion of NS will decrease 
plasma SIDa and contribute to metabolic acidosis. The 
observation by Van Regenmortel et  al. that a decreased 
SIDa (excluding lactate) did not have an impact on mor-
tality thus argues against a deleterious infusion-related 
role of chloride in se [1].
Several arguments strongly plead against a too pre-
cipitous verdict on NS. A randomized, controlled, dou-
ble-blind crossover study comparing the effects of a 2 L 
infusion of 0.9% NS versus Plasma-Lyte® in healthy vol-
unteers demonstrated significant reductions in mean 
renal artery flow velocity (P  =  0.045) and renal corti-
cal tissue perfusion (P =  0.008) from baseline after NS. 
However, there was no evidence of relevant acute kidney 
injury (AKI) as shown by similar concentrations of uri-
nary neutrophil gelatinase-associated lipocalin in both 
infusion groups [6]. A meta-analysis assessing high- ver-
sus low-chloride infusion in 6253 peri-operative and crit-
ically ill patients found a significant but weak association 
between high-chloride content fluids and a higher inci-
dence of AKI. Excluding the most heavy-weighted studies 
from this analysis, however, rendered the AKI end point 
non-statistically significant [7]. The subsequently pub-
lished 0.9% Saline versus Plasma-Lyte® for Intensive Care 
Unit Fluid Therapy trial found no difference in incidence 
of AKI, renal replacement therapy and mortality among 
patients receiving similar volumes of NS or buffered crys-
talloid [8]. Moreover, a very recent cluster-randomized 
crossover study comparing the administration of similar 
volumes of NS and balanced crystalloids in nearly 1000 
patients showed no difference in a composite “major kid-
ney-related adverse events” end point including death, 
dialysis, and persistent renal dysfunction [9]. Finally, the-
oretically beneficial effects of NS-induced acidosis such 
as enhanced tissue oxygen extraction and better protec-
tion against hypoxemia have insufficiently been investi-
gated [10].
An inherent but important limitation clouding the 
retrospective data of Van Regenmortel et  al. is the ina-
bility to correctly determine the fluid type and volume 
before ICU admission. Indeed, irrespective of the type 
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of admission (medical, surgical, or trauma) and after 
adjustment for important confounders (illness sever-
ity and comorbidities), the need to acutely administer a 
high volume of fluid or a positive fluid balance over time 
is independently and reproducibly associated with more 
ICU complications (including AKI [11, 12]) and higher 
mortality [13], especially in patients with underlying 
kidney or heart disease [14]. In addition, many ques-
tions remain unsolved. Are some patient subgroups more 
chloride-vulnerable? Is a “dose” limitation of NS (e.g., not 
exceeding 20–30  mL/kg) advised? Are pre-resuscitation 
chloride concentrations important? Does hyperchlo-
remia only matter when associated with SIDa changes or 
a particular degree of acidemia? Are all balanced crystal-
loids equivalent with regard to relevant clinical outcome 
parameters?
The study of Van Regenmortel et  al. indirectly under-
scores growing equipoise in the expert medical com-
munity regarding the presumed harmful effects of NS 
compared with balanced crystalloids. Future studies, 
such as the ongoing multicenter randomized Plasma-
Lyte® versus Saline (PLUS) trial, should hopefully defini-
tively unravel the crystalloid conundrum ate.
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